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Abstract
The canonical Wnt/b-catenin (Wnt) pathway is a master transcriptional regulatory signaling pathway that controls numerous
biological processes including proliferation and differentiation. As such, transcriptional activity of the Wnt pathway is tightly
regulated and/or modulated by numerous proteins at the level of the membrane, cytosol and/or nucleus. In the nucleus,
transcription of Wnt target genes by TCF/LEF-1 is repressed by the long Groucho/TLE co-repressor family. However, a
truncated member of the Groucho/TLE family, amino terminal enhancer of Split (AES) can positively modulate TCF/LEF-1
activity by antagonizing long Groucho/TLE members in a dominant negative manner. We have previously shown the
soluble intracellular domain of the LRP6 receptor, a receptor required for activation of the Wnt pathway, can positively
regulate transcriptional activity within the Wnt pathway. In the current study, we show the soluble LRP6 intracellular
domain (LRP6-ICD) can also translocate to the nucleus in CHO and HEK 293T cells and in contrast to cytosolic LRP6-ICD;
nuclear LRP6-ICD represses TCF/LEF-1 activity. In agreement with previous reports, we show AES enhances TCF/LEF-1
mediated reporter transcription and further we demonstrate that AES activity is spatially regulated in HEK 293T cells. LRP6-
ICD interacts with AES exclusively in the nucleus and represses AES mediated TCF/LEF-1 reporter transcription. These results
suggest that LRP6-ICD can differentially modulate Wnt pathway transcriptional activity depending upon its subcellular
localization and differential protein-protein interactions.
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Introduction
The canonical Wnt/b-catenin (Wnt) pathway is a ubiquitous
transcriptional regulatory pathway that affects the expression of
over 1800 genes involved in at least 36 different pathways
[1,2,3,4,5]. As a result, the Wnt pathway influences a diversity of
biochemical functions including cell patterning, differentiation,
embryonic development and apoptosis [1,2,3,5]. Defects at various
levels of the pathway therefore result in numerous pathological
conditions including various cancers and neurodegenerative
disorders [3,6].
In the absence of Wnt pathway activation, cytosolic b-catenin (a
co-activator for TCF/LEF-1) is phosphorylated by GSK3b and
CKIa [2,3,4,7]. Phosphorylation promotes b-catenin degradation
resulting in low basal levels of cytosolic b-catenin thus preventing b-
catenin nuclear translocation and activation of the Wnt responsive
transcription factor TCF/LEF-1 [2,3,8,9,10]. The TCF/LEF-1
family (TCF-1,-3, -4 and LEF-1) mediates expression of Wnt target
genes by acting as a repressor or activator of Wnt target genes
[9,10]. In the absence of significant nuclear b-catenin, DNA bound
TCF/LEF-1 proteins repress expression of Wnt target genes by
interacting with the long Groucho/TLE family of co-repressors
[8,9,10,11,12,13,14]. Long Groucho/TLE’s are pentadomain
proteins composed of highly conserved amino-terminal Q domain
(protein interaction and repression), followed by a GP domain
(repression), CcN domain (nuclear localization), an SP (repression)
and highly conserved WD40 domain (protein interaction)
[10,11,15]. The Q domain mediates interaction with transcription
factors such as TCF/LEF-1 as well as tetramerization of Groucho/
TLE members, which is essential for its repressor function and
interaction with TCF/LEF-1 [8,10,11,12,14,15,16,17,18,19,20].
The GP domainalsohas a critical repressor function as it is essential
for interaction between long Groucho/TLE’s and co-repressor
histone deacetylases (HDACs) [8,10,11,15,16,20,21].
In addition to the full-length Groucho/TLE members, there is
also a shorter member called amino-terminal enhancer of split
(AES) that contains only the Q and GP domains [10,11,12,
15,17,18,20,22,23]. AES is not an alternatively spliced variant of
the long Groucho/TLE gene but is a distinct family member
constitutively expressed from its own loci [10,18]. The Q domain
of AES and the long Groucho/TLE members both mediate
multimerization between AES and/or long Groucho/TLE
proteins [8,10,11,15,17,18,20,24] as well as interactions with
TCF/LEF-1 proteins [8,10,12,14]. However, the GP domain of
AES and long Groucho/TLE members are conserved but
functionally distinct, as AES does not interact with transcription-
ally repressive HDAC proteins [10,11,15,18,25]. Because AES
multimerizes with long Groucho/TLE members but does not
interact with HDAC’s, long Groucho/TLE proteins lose their
ability to form functional di/tetramers and/or bind transcription
factors [10,11,15,18]. As a result, AES can antagonize the
repressor function of long Groucho/TLE members [10,11,12,
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modulates TCF/LEF-1 activity [10,12]. Interestingly, AES can
function as a co-activator or co-repressor of various transcription
factors, which also distinguishes it from the dedicated repressor
function of long Groucho/TLE members [11,15,21]. AES is also
highly conserved among species as xenopus (NP_001083532) and
murine (NP_034477.1) homologs share ,90% and 99% protein
sequence identity to human AES (NP_001121.2).
Activation of the Wnt pathway requires interaction between the
secreted Wnt protein and two cell surface receptors, Frizzled (Fz)
and LRP6 (Low density lipoprotein receptor Related Protein
6)(the closely related LRP5 can also act as a co-receptor for certain
physiological processes) [2,3]. The ternary Wnt-Fz-LRP6 complex
inhibits cytosolic b-catenin phosphorylation/degradation, result-
ing in its cytosolic accumulation and translocation into the nucleus
[2,3,5,8,10,12,26]. Nuclear b-catenin directly interacts with TCF/
LEF-1 thereby displacing Groucho/TLE, which converts TCF/
LEF-1 from a transcriptional repressor to an activator of Wnt
target genes [3,5,8,9,10,12,21]. In addition to functioning at the
membrane as a primary activator of the Wnt pathway [2,4], our
group has shown exogenous LRP6 undergoes regulated intra-
membranous proteolysis (RIP) resulting in the release and
formation of a soluble LRP6 intracellular domain (LRP6-ICD)
[27].
While b-catenin mediated activation of TCF/LEF-1 requires
robust activation of the Wnt pathway [9], the transcriptional
activity of the Wnt pathway (i.e., b-catenin stabilization and/or
TCF/LEF-1 activity) can be modulated by various effector
proteins at the level of the membrane, cytosol and/or nucleus
[5,6,10,26,28,29,30,31,32,33,34,35,36]. We and others previously
have shown the LRP6-ICD can function as an effector of the Wnt
pathway by attenuating GSK3b mediated b-catenin phosphory-
lation thereby enhancing cytosolic b-catenin stabilization
[35,36,37,38,39]. LRP6-ICD expression also enhances TCF/
LEF-1 activity [35,36,38], which may be an indirect result of
enhanced b-catenin stabilization. However, the hypothesized
mechanism has yet to be confirmed, which is one aim of the
current study. It should also be noted that the LRP6-ICD is a
GSK3b substrate, but it does not have to be phosphorylated by
GSK3b to interact with [35,38] and attenuate GSK3b activity
[35]. It has been shown that the soluble intracellular domain of
various cell surface receptors, such as Fz and LRP1, can
translocate to the nucleus and directly modulate gene expression
[40,41,42,43,44]. While the cytosolic function of LRP6-ICD has
been studied [35,36,37,38,39], it is unknown if LRP6-ICD can
also translocate to the nucleus and directly modulate TCF/LEF-1
activity, which is the primary focus of the study.
Previously we reported that AES and LRP6-ICD interacted in a
yeast 2 hybrid assay [39] but the interaction was not confirmed in
situ. In the current study, we show the LRP6-ICD can translocate
to the nucleus where it interacts with AES. In contrast to cytosolic
LRP6-ICD, we show that nuclear localized LRP6-ICD represses
transcription of a TCF/LEF-1 reporter and depresses AES
mediated activation of the reporter. The current findings suggest
LRP6-ICD can differentially modulate Wnt pathway transcrip-
tional activity (i.e., b-catenin stabilization and/or TCF/LEF-1
activity) based upon its subcellular localization and protein-protein
interactions.
Materials and Methods
DNA Constructs
The GFP tagged wild type LRP6-ICD and LRP6-ICD65m
(Ser or Thr in all five PPP(S/T)P motifs were mutated to Ala and
this construct is not phosphorylated by GSK3b) were described
previously [35,39]. To make the GFP tagged LRP6-ICD
constructs with a nuclear localization signal (NLS) or nuclear
export signal (NES), wild type GFP-LRP6-ICD or GFP-LRP6-
ICD65 m were used as templates for PCR amplification. The
eGFP sequence from the pEGFP-C1 vector (BD Bioscience) was
amplified as part of the LRP6-ICD PCR product using the
following PCR primers: SalI-forward (59- ACG-CGT-CGA-CCG-
CCA-CCA-TGG-TGA-GCA-AGG-GCG-AGG-AG-39), BamHI-
forward (59-CGC-GGA-TCC-CGC-CAC-CAT-GGT-GAG-CAA-
GGG-CGA-GGA-G-39), NotI-reverse for wild type GFP-LRP6-ICD
(59-ATA-AGA-ATG-CGG-CCG-CTC-CGG-AGG-AGT-CTG-
TAC-AGG-GAG-AG-39)a n dNotI-reverse for GFP-LRP6-ICD
65m ( 5 9-ATA-AGA-ATG-CGG-CCG-CTC-CGG-AGG-AGT-
CTG-TAC-AGG-GAG-CGG-GTG-GCG-GTG-39). The amplified
GFP-LRP6-ICD products were digested with and subcloned into the
SalI and NotI site of the pCMV/myc/nuc empty vector (EV-NLS;
Invitrogen) or BamHI and NotI site of a pcDNA-NES empty vector to
make GFP-LRP6-ICD-myc-NLS or GFP-LRP6-ICD-NES con-
structs. The pCMV/myc/nuc/GFP vector (EV-GFP-NLS; Invitro-
gen) was used only as a control for assays involving GFP-LRP6-ICD-
NLS constructs. Using human AES cDNA as a template (accession #
NM_001130, 197 amino acids), the following PCR primers, digestion
and vector were used to make the AES-HA construct: EcoRI-forward
(59-GCC-GGG-ATC-CAC-ATG-ATG-TTT-CCA-CAA-AGC-AG-
39)a n dEcoRI-reverse (59-CCG-GCC-TCG-AGC-TAA-TCC-GAC-
TTC-TCG-CCA-TC-39), digested with and subcloned into the EcoRI
siteofanHAexpressionvector[35].Tomake theAES-myc-NLSor
AES-HA-NES constructs using AES-HA as a template, the
following PCR primers, digestion and vectors were used for each:
NcoI-forward (59-CAT-GCC-ATG-GCA-TGA-TGA-TGT-TTC-
CAC-AAA-GCA-GGC-ATT-C-39) and XhoI-reverse (59-CCG-
CTC-GAG-CGG-TCC-ATC-CGA-CTT-CTC-GCC-ATC-39),
digested with and subcloned into the NcoI and XhoI site of the
pCMV/myc/nuc vector; BamHI-forward (59-CGC-GGA-TCC-
ATG-ATG-TTT-CCA-CAA-AGC-AGG-CAT-TC-39) and NotI-
reverse (59-ATA-AGA-ATG-CGG-CCG-CAA-TGC-GTA-ATC-
TGG-AAC-ATC-GTA-TGG-G-39), digested with and subcloned
into the BamHI and NotI site of the pcDNA-NES vector. The
pcDNA-NES vector (from Soner Gundemir, unpublished data)
contains the NES of PKI alpha in a pcDNA3.1(+) (Invitrogen)
backbone.Theintegrityofallconstructs was confirmedby sequence
analysis. Cytosolic and nuclear localization of the NES, NLS and
untagged constructs was confirmed by subcellular fractionation
(Fig. 1).
Cell Culture and Transient Transfections
CHO and HEK 293T cells (ATCC) were maintained in
Dulbecco’s Modified Eagle medium containing 10% FBS. All
transient transfections were done using FuGENE 6 transfection
reagent (Roche Applied Science) according to the manufacturer’s
protocol. The final amount of cDNA transfected into the cells was
always equalized by using a control b-galactosidase (LacZ) or
eGFP unless otherwise noted.
Luciferase Assay
One day before transfection, 6.0610
4 HEK 293T cells were
plated in a 12-well plate. Cells were transfected 24 hrs later with
0.2 mg LEF-1 (from Dr. R Grosschedl), 0.005 mg TK-Renilla
internal control (Promega) and 0.2 mg TOPflash-luciferase report-
er (TOP; Upstate) or the negative control reporter, Super8-
XFOPflash (FOP; Addgene), whose TCF/LEF-1 binding sites
have been mutated. Additionally, cells were transfected with AES-
HA (0.5 mg), AES-myc-NLS (0.5 mg), AES-HA-NES (0.25 mg),
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GFP-LRP6-ICD-NES (0.25 mg). The empty NLS vectors (EV-
NLS or EV-GFP-NLS) significantly activated the TOP reporter
compared to lacZ or eGFP while the empty pcDNA-NES also had
a slight activating effect on the TOP reporter. In contrast to the
empty NLS vectors, the activating effect of pcDNA-NES was
mitigated by using a lower cDNA concentration. Neither the
empty NLS nor NES vectors affected the FOP reporter. However,
to mitigate possible confounding variables, the NLS or NES
tagged AES-HA and GFP-LRP6-ICD constructs are expressed as
fold change relative to the empty NLS or NES vectors. Equal
amount of cDNA for the empty NLS or NES vectors and the NLS
or NES tagged AES-HA and/or GFP-LRP6-ICD constructs was
used in all assays. All experiments were performed at least three
times and each time the measurements were done in triplicate.
Immunblotting, b-catenin assay and Antibodies
Proteins samples were electrophoresed on 10% SDS-polyacryl-
amide gels (SDS-PAGE), transferred to nitrocellulose membranes
and immunoblotted as previously described [35,39]. Determina-
tion of endogenous total cellular b-catenin or cytosolic phospho-b-
catenin and total cytosolic b-catenin were carried out using lysis
buffer (10 mM Tris, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.05%
Nonidet P-40, 1 mM EGTA with phosphatase and protease
inhibitors) or non-detergent lysis buffer as previously described
[2,35,36]. The following primary antibodies were used: polyclonal
anti-phospho-b-catenin (Ser 33/37, Thr 41, Cell Signaling),
monoclonal anti-b-catenin (BD Biosciences), monoclonal anti-
GFP (Roche), monoclonal anti-HA (Sigma), monoclonal anti-
histoneX (Chemicon), monoclonal anti-myc (Cell Signaling), and
monoclonal anti-a-tubulin (Sigma).
Nuclear Fractionation
Separation of cytosolic and nuclear fractionation was carried as
previously described [45]. Briefly, cells were washed twice with
and harvested in ice-cold PBS and a small aliquot of the total
lysate was collected before centrifugation and resuspended in lysis
buffer (represents whole cell lysate). The remaining lysate was spun
at 800 x g for 5 min at 4uC and the cell pellet was resuspended in
lysis buffer by triturating followed by centrifugation at 3806g for
5 min at 4uC. The supernatants were collected and used as the
cytosolic fractions. The pellets were washed once in lysis buffer
and twice in wash buffer (30 mM sucrose, 10 mM Pipes, pH 6.8,
3 mM MgCl2, 1 mM EGTA, 25 mM NaCl with phosphatase and
protease inhibitors). The crude nuclei were overlaid on top of 1 m
sucrose and spun at 12006g for 10 min at 4uC. The pellets were
collected and resuspended in buffer B (300 mM sucrose, 10 mM
Pipes, pH 6.8, 3 mM MgCl2, 1 mM EGTA, 25 mM NaCl, 0.5%
Triton X-100 with phosphatase and protease inhibitors) and used
as the nuclear fractions.
Immunoprecipitation
HEK 293T cells were co-transfected with 4 mg of AES-HA
along with 5 mg of eGFP-C1 (eGFP), wild type GFP-LRP6-ICD or
GFP-LRP6-ICD65 m. Forty-eight hours post transfection, the
AES-HA/eGFP cells were collected with immunoprecipitation
buffer (0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris-Cl
(pH 7.4), 1 mM EGTA and 1 mM EDTA with phosphatase and
protease inhibitors) while the AES-HA/GFP-LRP6-ICD cell’s
were fractionated into cytosolic and nuclear fractions. For
immunoprecipitation, cytosolic or nuclear fractions (50 mg) were
incubated at 4uC for 3 hrs on a rotational shaker with M-280
sheep anti-mouse magnetic IgG beads (Invitrogen/Dynal Biotech)
preconjugated to a monoclonal anti-HA antibody (Sigma) in the
presence of immunoprecipitation buffer. Cytosolic or nuclear
precipitates (and their respective controls) were washed 66 with
PBS containing 350 mM NaCl (high salt) and 0.2% Triton X-100
or 26/26with high salt PBS/regular PBS. The beads were boiled
for 10 min in 26stop buffer (2% sodium dodecyl sulfate, 250 mM
Tris-Cl (pH 7.4), 10% glycerol, 5 mM EDTA and 5 mM EGTA)
and subjected to SDS-PAGE and immunoblot analysis.
Immunofluorescence
Cells were plated onto poly-D-lysine/laminin coated glass
coverslips (20/5 mg/ml) and transfected with the indicated
constructs for 48 hrs. Cells were fixed with 4% PBS-paraformal-
dehyde for 15 min, permeabilized with ice cold methanol for
5 min and stained with anti-GFP or anti-HA antibody at 4uC
overnight. Cells were then washed with PBS and incubated with
5% FBS containing a Texas red- or FITC -conjugated secondary
Figure 1. Expression and Subcellular localization of LRP6-ICD and AES constructs. Representative immunoblot of cell lysates from HEK
293T cells which were transiently transfected with LRP6-ICD and AES constructs. Twenty-four hrs post-transfection cells were separated into cytosolic
and nuclear fraction and immunoblotted. Lysate (L), cytosolic (C) and nuclear (N) fractions. NES: nuclear export signal. NLS: nuclear localization signal.
(A) GFP tagged LRP6-ICD constructs with or without an ‘‘NES’’ or ‘‘NLS’’ tag were detected with an anti-GFP antibody. (B) AES-HA (no localization
signal) and AES-HA-NES or AES-myc-NLS constructs were detected with an anti-HA or anti-myc antibody. (C) Histone (nuclear marker) and a-tubulin
(cytosolic marker) for the non-fractionated and fractionated lysates shows the relative purity of the fractions.
doi:10.1371/journal.pone.0011821.g001
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Vector Labs) at room temperature for 1 hr. Slides were analyzed
using a Zeiss Axio Observer inverted microscope with a 636oil
immersion objective. Images were captured with an Axio-
CamMR3 camera (Zeiss Corp) and exported using the AxioVision
software (Zeiss Corp.).
Data Analysis
Data were analyzed using ANOVA between individual groups
and considered significantly different when p,0.05. Results were
expressed as mean 6 S.E.
Results
LRP6-ICD translocates to the nucleus
It has been shown exogenous LRP6-ICD localizes to the cytosol
[36] but nuclear localization of the ,20 kDa (,50 kDa with GFP
tag) protein has not been examined. Figure 2 clearly shows
exogenous wild type LRP6-ICD and a phospho-mutant LRP6-
ICD that can not be phosphorylated by GSK3b (LRP6-
ICD65 m) also localize to the nucleus in CHO cells. Although
the presence of nuclear LRP6-ICD was evident, the level of
nuclear LRP6-ICD relative to cytosolic LRP6-ICD (Fig. 2A),
suggests that the majority of LRP6-ICD remains in the cytosol.
Immunocytochemistry (Fig. 2B) also show that both wild type
LRP6-ICD and LRP6-ICD65 m localize within DAPI stained
nuclei which confirms the fractionation data showing nuclear
localization of LRP6-ICD does not require GSK3b phosphoryla-
tion. Interestingly, nuclear LRP6-ICD exhibits punctuate nuclear
staining whereas cytosolic LRP6-ICD exhibits a more diffuse
pattern similar to eGFP. Both LRP6-ICD constructs also exhibited
similar nuclear localization in HEK 293T cells (Fig. 1a and Fig.
S1). It should also be noted that the subcellular distribution of
LRP6-ICD was not significantly altered by co-expression with
LEF-1 and/or transcriptional activation of the Wnt pathway by
LiCl [7] (data not shown).
LRP6-ICD differentially modulates TCF/LEF-1 dependent
transcription
The TOPflash luciferase reporter (TOP) contains six TCF/
LEF-1 binding sites and is a commonly used measure of Wnt
pathway mediated TCF/LEF-1 transcriptional activity [2,3,4,10,
12,26,28,29,36,38]. Because it is primarily cytosolic (Fig. 1a, 2,
and Fig. S1), it is speculated exogenous LRP6-ICD indirectly
enhances TOP transcription through amplification of cytosolic b-
catenin. However, it is also possible that TCF/LEF-1 activity
can be modulated by nuclear LRP6-ICD. To gain a better
understanding how localization affects LRP6-ICD’s ability to
Figure 2. LRP6-ICD localizes to the nucleus and localization is independent of PPP(S/T)P phosphorylation. (A) CHO cells were
transfected with wild-type GFP-LRP6-ICD (WT-ICD) or GFP-LRP6-ICD65 m (M-ICD) for 48 hrs. Nuclear and cytosolic fractions were blotted and
sequentially probed for GFP, tubulin (cytosolic marker) and histone (nuclear marker). 20 ug and 5 ug of total nuclear and cytosolic protein were
loaded. (*) indicates long exposure and (**) short exposure respectively. (B) CHO cells were transfected with eGFP (empty vector) or wild-type GFP-
LRP6-ICD (GFP-WT-ICD) or GFP-LRP6-ICD65 m (GFP-M-ICD) for 48 hrs. GFP constructs were detected with anti-GFP antibody (middle column; green)
and then stained with DAPI to identify nuclei (left column; blue). DAPI and GFP pictures were merged to show nuclear localization of GFP constructs
(right column).
doi:10.1371/journal.pone.0011821.g002
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HEK 293T cells transiently transfected with LRP6-ICD (non-
targeted) or LRP6-ICD possessing a nuclear export signal
(NES) or nuclear localization signal (NLS). Nuclear fractionation
of the transfected cells (Fig. 1a) show LRP6-ICD is primarily
localized to the cytosol whereas ,80% of the LRP6-ICD-NLS
construct localizes to the nucleus. As expected, LRP6-ICD-NES is
exclusively cytosolic. In agreement with published results [35,36,
37,38,39], LRP6-ICD amplified endogenous cytosolic b-catenin
levels by decreasing its phosphorylation (Fig. 3d), and significantly
amplified TOP transcription by ,30% (Fig. 3a). Similar to LRP6-
ICD [35,36,37,38,39], cytosolic LRP6-ICD (i.e., LRP6-ICD-NES)
stabilized endogenous cytosolic b-catenin (Fig. 3d) and enhanced
TOP transcription by ,40% (Fig. 3b). No significant difference in
b-catenin stabilization was seen between LRP6-ICD and LRP6-
ICD-NES which supports the observation that LRP6-ICD is
primarily cytosolic. Unexpectedly, nuclear targeted LRP6-ICD
(i.e. LRP6-ICD-NLS) repressed TOP transcription by ,38%
(Fig. 3c), which suggest nuclear LRP6-ICD functions as a negative
TCF/LEF-1 modulatory protein. In accord with previous findings
[35] and demonstrated by exogenous LRP6-ICD65 m (which
cannot be phosphorylated by GSK3b), cytosolic LRP6-ICD
functions independent of GSK3b phosphorylation (Figs. 3a, b
and d). Here we also show that nuclear LRP6-ICD does not have
to be phosphorylated by GSK3b to negatively modulate TCF/
LEF-1 activity (Fig. 3c). It should be noted that the TOP data can
not be compared between LRP6-ICD, LRP6-ICD-NES and/or
LRP6-ICD-NLS as the empty NES (pcDNA-NES) and NLS (EV-
GFP-NLS) vectors activated TOP activity compared to lacZ or
eGFP (see Materials and Methods). Modulation of TCF/LEF-1
activity was specific as none of the expression constructs
significantly affected the mutant TCF/LEF-1 luciferase reporter
(FOPflash; FOP) or the transfection control reporter (TK-Renilla;
data not shown). The LRP6-ICD-NES results confirm the premise
that cytosolic LRP6-ICD indirectly modulates TCF/LEF-1
activity through b-catenin. Additionally, the TOP data suggest
exogenous LRP6-ICD, depending on its subcellular localization
(i.e. cytosolic or nuclear), can differentially function within the Wnt
pathway by positively or negatively modulating TCF/LEF-1
activity.
Nuclear AES positively modulates TCF/LEF-1 dependent
transcription
AES is a ubiquitously expressed ,25 kDa cytosolic and/or
nuclear protein [10,12,14,17,22]. Although AES lacks a putative
NLS [11,15] its subcellular distribution is cell type and possibly
context dependent [12,14,17,22,46]. Fractionation of HEK
293T cells expressing a non-targeted AES-HA construct (i.e.
AES) demonstrates AES is a nucleocytoplasmic protein that
exhibits a high cytosol:nuclear localization ratio (Fig. 1b and
Fig. S1). It has been shown xenopus and mouse AES (,90%
and 99% protein sequence identity to human AES) can enhance
TCF/LEF-1 dependent TOP transcription [10,12] by antago-
nizing the repressor function ofl o n gG r o u c h o / T L Em e m b e r s
Figure 3. LRP6-ICD differentially impacts TCF/LEF-1 activity in a spatially relevant manner. HEK 293T cells were transfected with
luciferase assay reporter constructs along with (A) control eGFP, wild type GFP-LRP6-ICD (WT-ICD) or GFP-LRP6-ICD65 m (M-ICD) for 24 hrs (B)
control pcDNA-NES, wild type GFP-LRP6-ICD-NES (WT-ICD-NES or GFP-LRP6-ICD65 m-NES (M-ICD-NES) for 48 hrs (C) control EV-GFP-NLS, wild type
GFP-LRP6-ICD-NLS (WT-ICD-NLS) or GFP-LRP6-ICD65 m-NLS (M-ICD-NLS) for 24 hrs and TCF/LEF-1 activity was measured. TCF/LEF-1 activity for the
LRP6-ICD constructs is expressed as a percentage of the relevant control used in each condition: (*P,0.01, **P,0.001, ***P,0.0001). (D) HEK 293T
cells were transfected with control eGFP, WT-ICD, M-ICD, WT-ICD-NES or M-ICD-NES. Twenty-four hrs post-transfection, cells were collected and
cytosolic fractions were probed for endogenous cytosolic phospho-b-catenin (Ser33/37/Thr41) or total endogenous cytosolic b-catenin. Total cellular
b-catenin levels did not change.
doi:10.1371/journal.pone.0011821.g003
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positive modulator of the Wnt pathway as transient transfection
of AES amplified TCF/LEF-1 dependent TOP transcription by
,105%. It is speculated that AES functionally modulates
transcription in the nucleus, but AES has also been shown to
function in the cytosol [22]. To determine if AES mediated
TOP transcription is spatially regulated, the TOP assay was
utilized in HEK 293T cells transiently transfected with NES or
NLS tagged AES constructs. Figure 1b shows the NES or NLS
tagged AES constructs localize almost exclusively to the cytosol
or nucleus. Whereas cytosolic AES (i.e. AES-NES) does not
affect TOP transcription (Fig. 4b), nuclear targeted AES (i.e.
AES-NLS) significantly enhances TOP transcription (Fig. 4c).
Transcriptional modulation of TOP was specific for TCF/LEF-
1 as none of the expression constructs significantly affected FOP
or the transfection control reporter (TK-Renilla;d a t an o t
shown). Neither AES nor cytosolic AES affected stabilization
of endogenous cytosolic b-catenin (Fig. 4d) which was not
unexpected since AES does not interact with b-catenin [8]. The
results clearly show AES positively modulates TCF/LEF-1
activity and that AES functional activity is spatially regulated in
HEK 293T cells. Similar to LRP6-ICD, AES subcellular
distribution was not significantly altered by co-expression with
LEF-1 and/or transcriptional activation of the Wnt pathway by
LiCl [7] (data not shown).
LRP6-ICD interacts with AES in the nucleus
Previously we reported the LRP6-ICD interacted with AES in a
yeast 2 hybrid assay [39] and AES is moderately expressed in
HEK 293T cells [10,22]. Therefore, interaction with a nuclear
protein that positively modulates TCF/LEF-1 activity, such as
AES (Fig. 4c), is a possible mechanism by which nuclear targeted
LRP6-ICD negatively modulates TCF/LEF-1 activity (Fig. 3c).
To determine a possible interaction, HEK 293T cells were co-
transfected with AES and LRP6-ICD, fractionated and a co-
immunoprecipitation assay (CoIP) was carried out on the cytosolic
and nuclear fractions. The CoIP confirms the yeast 2 hybrid data
that LRP6-ICD interacts with AES in situ (Fig. 5a) and that the
interaction is exclusively nuclear (Fig. 5a; GFP blot, lane 4). The
data also shows the AES/LRP6-ICD interaction does not require
GSK3b mediated phosphorylation of LRP6-ICD as the nuclear
phospho-mutant LRP6-ICD65 m interacted with AES (Fig. 5a;
GFP blot, lane 5). The control samples confirm the absence of a
non-specific interaction between the constructs, anti-HA antibody
and/or magnetic beads (Fig. 5a; GFP blot, lanes 1–3).
Nuclear LRP6-ICD represses AES mediated activation of
TCF/LEF-1 dependent transcription
By interacting with AES in the nucleus, it is possible that
nuclear targeted LRP6-ICD repressed TCF/LEF-1 dependent
TOP transcription (Fig. 3d) by repressing AES mediated
Figure 4. AES mediates activation of TCF/LEF-1 in a subcellular localization-dependent manner. HEK 293T cells were transfected with
luciferase assay reporter constructs along with (A) control LacZ or AES-HA (AES) for 24 hrs (B) control pcDNA-NES or AES-HA-NES (AES-NES) for 48 hrs
(C) control EV-NLS or AES-myc-NLS (AES-NLS) for 48 hrs and TCF/LEF-1 activity was measured. TCF/LEF-1 activity for the AES constructs is expressed as
a percentage of the relevant control used in each condition: (*P,0.01, ***P,0.0001). (D) HEK 293T cells were transfected with control LacZ, AES or
AES-NES. Twenty-four hrs post-transfection, cells were collected and cytosolic fractions were probed for endogenous cytosolic phospho-b-catenin
(Ser33/37/Thr41) or total endogenous cytosolic b-catenin. Total cellular b-catenin levels did not change.
doi:10.1371/journal.pone.0011821.g004
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measured in HEK 293T cells co-transfected with AES along with
LRP6-ICD, LRP6-ICD-NES or LRP6-ICD-NLS. As shown
above, AES overexpression induced TOP transcription (Fig. 4a)
but co-expression with LRP6-ICD, which exhibits nuclear
localization, significantly repressed AES mediated TOP transcrip-
tion by ,65% (Fig. 6a). When LRP6-ICD was excluded from the
nucleus, AES transcriptional activity was not repressed (Fig. 6b),
but repression was re-established when LRP6-ICD was targeted to
the nucleus (,137.6%; Fig. 6c). Repression of AES mediated TOP
transcription by nuclear targeted LRP6-ICD and not cytosolic
LRP6-ICD combined with the CoIP/interaction data (Fig. 5a)
demonstrate LRP6-ICD and AES functionally interact exclusively
in the nucleus.
Discussion
The Wnt signaling pathway is a dynamic and complex
transcriptional regulatory pathway whose activation or repression
influences the expression of nearly 2,000 genes affecting cell
processes from proliferation to differentiation [1,3,5]. Robust
activation of the pathway is required to initiate expression of Wnt
target genes [8,9], but similar to other pathways [47,48,49,50],
transcriptional activity of the pathway can be positively or
negatively modulated by various extracellular, cytosolic and/or
nuclear proteins [5,6,10,26,28,30,31,32,33,35,36,51]. Therefore,
transcriptional activity of the Wnt pathway does not exclusively
exist in an ‘‘on’’ or ‘‘off’’ state but can range from high to low
activity as a method to fine tune pathway activity/output in
response to the dynamic cellular environment [5,6,10,26,28,
29,30,31,32,33,34,35,36].
Through various protein-protein interactions and post-transla-
tional modifications, Wnt pathway transcriptional activity is
commonly modulated by influencing the stability and/or activity
of cytosolic/nuclear b-catenin [2,3,5,52,53,54,55,56] as well as the
transcriptional activity of TCF/LEF-1 [3,8,9,10,13,30,31]. In this
study, we report a novel modulatory function for the soluble LRP6
intracellular domain (LRP6-ICD), the proteolytic product of
LRP6, in that it can positively or negatively modulate Wnt
pathway transcriptional activity (i.e., b-catenin stabilization and/
or TCF/LEF-1 activity) depending upon its subcellular localiza-
tion and differential protein-protein interactions. Cytosolic LRP6-
ICD positively modulates TCF/LEF-1 activity indirectly through
b-catenin. Further, we show the LRP6-ICD can translocate to the
nucleus where it negatively modulates TCF/LEF-1 activity by
interacting with and repressing nuclear AES, a positive TCF/LEF-
1 modulatory protein [10,12]. We also demonstrate the functional
relationship between LRP6-ICD and AES is exclusively nuclear.
Cleavage, release, nuclear translocation and subsequent tran-
scriptional modulation by the soluble intracellular domain (ICD)
of a transmembrane receptor is a novel signaling mechanism that
has been demonstrated for various cell surface receptors including
Fz and the LRP6 family member, LRP1 [40,41,42,43,44]. As a
result, such receptors (e.g., LRP -1 and -6 and Fz) can modulate
transcription through multiple mechanisms. In some cases both
the full length receptor and corresponding soluble ICD similarly
affect transcription (e.g., Fz) [40,44] whereas certain ICD’s
differentially affect transcription compared to their full length
receptor (e.g., PC1, LRP1) [43,57]. In this respect and similar to
LRP1/LRP1-ICD, activated full length LRP6 positively affects
transcription whereas the soluble nuclear LRP6-ICD negatively
modulates TCF/LEF-1 activity.
While modulation of TCF/LEF-1 activity by LRP6-ICD or
AES was significant, the scale of modulation in relation to
overexpression clearly indicates that both proteins act as
modulators and not primary effectors of Wnt pathway transcrip-
tional activity. Although expression of endogenous Wnt target
genes has been shown for primary activators of the Wnt pathway
[2], no significant changes could be detected for LRP6-ICD or
AES (data not shown). This was not unexpected as robust
activation of the pathway, as shown for overexpression of primary
activators, is required to initiate expression of Wnt target genes
[8,9]. It is also possible that LRP6-ICD and/or AES are capable of
modulating only a specific subset of TCF/LEF-1 dependent Wnt
target genes that were not included in our analysis.
Although differential modulation of transcription has been
shown for non-ICD proteins, such as Hipk1 which differentially
modulates b-catenin:TCF/LEF-1 transcription [32], there are no
reports to our knowledge showing a particular ICD can
differentially modulate transcription [40,41,42,43,44,57,58]. We
demonstrate here for the first time [41,42], to our knowledge, that
a released ICD has dual functions as both a positive and negative
modulator of transcription whose functional activity is dictated by
a combination of localization and differential protein-protein
Figure 5. LRP6-ICD associates with AES in the nucleus. HEK 293T cells were co-transfected with GFP-LRP6-ICD, GFP-LRP6-ICD65 m or eGFP-C1
along with AES-HA. Forty-eight hrs post-transfection cells were separated into cytosolic and nuclear fractions. (A) Cytosolic and nuclear fraction were
immunoprecipitated with an anti-HA antibody against AES-HA and the presence of the GFP tagged LRP6-ICD constructs was detected in the
immunoprecipitate with an anti-GFP antibody. The immunoblot was then reprobed with an anti-HA antibody. The first three lanes represent controls
for non-specific interaction between the anti-HA antibody, beads and/or constructs. Note: (*) refers to control lysate that was incubated with non-
immune mouse IgG1 antibody to prevent non-specific binding. (B) Blots showing expression of indicated constructs for each sample in the cytosolic
and nuclear fraction (5 mg/fraction).
doi:10.1371/journal.pone.0011821.g005
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pathway activity by interacting with [35,38,39] and attenuating
GSK3b [35,37,38,39], a negative Wnt pathway regulator, which
indirectly up-regulates TCF/LEF-1 activity through enhanced b-
catenin stabilization. However, nuclear LRP6-ICD negatively
modulates TCF/LEF-1 activity by interacting with AES, which
functions in a dominant negative manner over the TCF/LEF-1
repressive activities of long Groucho/TLE members. By interact-
ing with and possibly sequestering AES, nuclear LRP6-ICD may
attenuate the dominant negative activity of AES, thereby allowing
long Groucho/TLE members to reengage in full repression of
TCF/LEF-1.
We show that the functional activity of LRP6-ICD and AES as
well as their functional relationship is regulated in part by
localization. Both proteins lack a putative NES or NLS and
therefore regulation by the importin or exportin family of proteins
seems unlikely [59]. Although the size of LRP6-ICD (,20 kDa)
and AES (,25 kDa) allow for nuclear diffusion [60], it is
reasonable to assume the transcriptional activity of the Wnt
pathway is not modulated by the random diffusion of effector
proteins. Subcellular distribution of LRP6-ICD does not appear to
be affected by cell type as we showed it is primarily cytosolic in
CHO, HEK 293T and COS (data not shown) cells which suggests
LRP6-ICD functions primarily as a positive modulator within the
Wnt pathway. Perhaps similar to the soluble Fz-ICD [40], LRP6-
ICD nuclear localization is regulated through interaction with
other proteins in a context-dependent manner. In contrast, AES
subcellular distribution appears to be influenced by cell type as it is
exclusively nuclear in Gonadotropin releasing neurons [17],
cytosolic in COS cells [12,14] and here we show nucleocytoplas-
mic distribution in HEK 293T cells. Although AES is primarily
cytosolic in HEK 293T cells, we show nuclear AES functionally
modulates TCF/LEF-1 dependent transcription. This suggests
AES activity is also spatially regulated in HEK 293T cells. It
should be noted that transcriptional activation of the Wnt pathway
by LiCl [7] and/or co-expression of LEF-1 did not significantly
alter the subcellular distribution of LRP6-ICD or AES in HEK
293T cells (data not shown). Therefore, we were unable to
determine the regulatory mechanism(s) and/or proteins that
mediate their subcellular distribution.
Figure 6. Repression of AES mediated TCF/LEF-1 transcription by nuclear LRP6-ICD. HEK 293T cells were transfected with luciferase assay
reporter constructs (TOP reporter) along with (A) control LacZ, control LacZ and AES-HA (AES) or AES-HA and GFP-LRP6-ICD (ICD) for 24 hrs (B)
control LacZ and control pcDNA-NES, control pcDNA-NES and AES-HA or AES-HA and GFP-LRP6-ICD-NES (ICD-NES) for 48 hrs (C) control LacZ and
control EV-GFP-NLS, control EV-GFP-NLS and AES-HA or AES-HA and GFP-LRP6-ICD-NLS (ICD-NLS) for 24 hrs and TCF/LEF-1 activity was measured.
TCF/LEF-1 activity is expressed as a percentage of the relevant control(s) used in each condition: (**P,0.001).
doi:10.1371/journal.pone.0011821.g006
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depends on the concentrations of long Groucho/TLE and b-
catenin protein(s) in the nucleus and their affinities for TCF/LEF-
1 proteins [8]. This delicate balance is important as Wnt pathway
transcriptional activity influences a broad range of cellular
functions. For example, the balance between long Groucho/
TLE members (via HDAC recruitment) and b-catenin on TCF
transcriptional activity regulates oligodendrocyte differentiation,
timing of differentiation and maturation [13]. Therefore, effector
proteins such as AES and/or LRP6-ICD which are capable of
modulating TCF/LEF-1 activity through long Groucho/TLE
and/or b-catenin, have the potential to influence Wnt pathway
mediated cellular functions such as proliferation/differentiation.
However, the influence modulatory proteins have on cellular
function can be difficult to quantify for it can be influenced by
environmental cues, cell type, specific cellular function analyzed
and/or the magnitude by which Wnt pathway transcriptional
activity is modulated, just to name of few.
In summary, we show the soluble LRP6-ICD differentially
modulates Wnt pathway transcriptional activity depending upon
its subcellular localization and differential protein-protein interac-
tions. In future studies it will be interesting to further examine how
the LRP6-ICD/AES interaction affects cellular function mediated
by the Wnt pathway and the cellular cues that regulate their
functional localization.
Supporting Information
Figure S1 Subcellular distribution of LRP6-ICD and AES in
HEK 293T cells. HEK 293T cells were transfected with eGFP (top
row), GFP-LRP6-ICD (middle row) or AES-HA (bottom row) for
48hrs and stained with anti-GFP or anti-HA antibody and DAPI
as previously described.
Found at: doi:10.1371/journal.pone.0011821.s001 (0.60 MB TIF)
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